EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB-Expressing Breast Cancer (vol 33, pg 1609, 2015)

Yardley D. A.; Weaver R.; Melisko M. E.

首页> 外文期刊>Journal of Clinical Oncology >EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB-Expressing Breast Cancer (vol 33, pg 1609, 2015)

【24h】

EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB-Expressing Breast Cancer (vol 33, pg 1609, 2015)

机译：新兴：晚期药物糖蛋白NMB表达的乳腺癌中抗体-药物偶联物格伦巴单抗Vedotin的随机II期研究（第33卷，第1609页，2015年）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of Clinical Oncology》 |2015年第18期|共1页
作者
Yardley D. A.; Weaver R.; Melisko M. E.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB-Expressing Breast Cancer (vol 33, pg 1609, 2015) [J] . Yardley D. A., Weaver R., Melisko M. E. Journal of Clinical Oncology . 2015,第18期

机译：新兴：晚期药物糖蛋白NMB表达的乳腺癌中抗体-药物偶联物格伦巴单抗Vedotin的随机II期研究（第33卷，第1609页，2015年）
2. EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB-Expressing Breast Cancer [J] . Yardley Denise A., Weaver Robert, Melisko Michelle E., Journal of Clinical Oncology . 2015,第14期

机译：新兴：在晚期糖蛋白NMB表达乳腺癌中抗体-药物结合的格伦巴单抗维多汀的随机II期研究。
3. EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB-Expressing Breast Cancer [J] . Yardley Denise A., Weaver Robert, Melisko Michelle E., Journal of Clinical Oncology . 2015,第14期

机译：出现：随机期II研究在晚期糖蛋白NMB表达乳腺癌中的抗体 - 药物缀合物Glembatumumab Vedotin研究
4. Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer -ECRIN group studies [C] . Sakamoto J, Kodera Y, Kobayashi M, International Gastric Cancer Congress . 2009

机译：I / II期临床试验关于每周紫杉醇（WPTX）和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
5. Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Advanced Melanoma [O] . Patrick A. Ott, Omid Hamid, Anna C. Pavlick, -1

机译：晚期黑素瘤患者抗体-药物结合的格伦巴单抗Vedotin的I / II期研究
6. Phase I/II study of the antibody-drug conjugate glembatumumab vedotin in patients with locally advanced or metastatic breast [O] . Johanna Bendell, Suzanne Jones, A. N. Rose, 2014

机译：局部晚期或转移性乳腺癌患者抗体 - 药物偶联物glembatumumab vedotin的I / II期研究

EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB-Expressing Breast Cancer (vol 33, pg 1609, 2015)

著录项

相似文献

相关主题

期刊订阅